Here are seven new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.
Adefovir dipivoxil tablet: Apotex Corp has discontinued 10 milligram Adefovir Dipivoxil tablets, an antiviral medication used to treat hepatitis B infection. No further details were provided.
Clindamycin phosphate; benzoyl peroxide gel: Teva Pharmaceuticals has discontinued the combination topical gel containing clindamycin phosphate and benzoyl peroxide (25 mg/1 gram; 10 mg/1 gram) for dermatological use. The decision was based on business reasons.
Esterified estrogens tablet: Pfizer has discontinued Menest tablets in multiple strengths, 0.3 mg, 0.625 mg, 1.25 mg and 2.5 mg, used in endocrinology and metabolism treatments.
Fluocinolone acetonide intravitreal treatment: Ani Pharmaceuticals’ Yutiq 0.18 mg intravitreal implant, used for chronic non-infectious uveitis affecting the posterior segment of the eye, is on long-term back order with no estimated resupply date. Alternative implants such as Iluvien 0.19 milligram and Bausch Health’s Retisert are available but differ in delivery and dosage.
Irinotecan hydrochloride injection: Fresenius Kabi and Teva Pharmaceuticals are discontinuing various strengths of irinotecan hydrochloride injections used in oncology. Fresenius Kabi’s 40 mg/2 milliliter and 100 mg/5 milliliter vials were discontinued and Teva’s 20 mg/1 milliliter injections are expected to be unavailable beyond mid-September to mid-October.
Mometasone furoate aerosol for oral inhalation: Organon reports a shortage of Asmanex HFA inhalers in 50 mcg and 100 mcg strengths due to increased demand. The company expects to restock the products by mid-August. Asmanex Twisthaler and 200 mcg inhalers remain available.
Voriconazole tablet: Pfizer has discontinued Vfend 50 mg tablets; it is an antifungal medication used to treat serious infections.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
